Mark Murray
2019 - Arbutus Biopharma Corp
In 2019, Mark Murray earned a total compensation of $3.8M as Former President and Chief Executive Officer at Arbutus Biopharma Corp, a 50% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,193,684 |
|---|---|
| Salary | $273,491 |
| Other | $2,313,255 |
| Total | $3,780,430 |
Murray received $2.3M in other compensation, accounting for 61% of the total pay in 2019.
Murray also received $1.2M in option awards and $273.5K in salary.
Rankings
In 2019, Mark Murray's compensation ranked 3,179th out of 13,971 executives tracked by ExecPay. In other words, Murray earned more than 77.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,179 out of 13,971 | 77th |
Division Manufacturing | 1,148 out of 5,695 | 80th |
Major group Chemicals And Allied Products | 389 out of 2,194 | 82nd |
Industry group Drugs | 319 out of 1,880 | 83rd |
Industry Pharmaceutical Preparations | 235 out of 1,392 | 83rd |
Source: SEC filing on April 24, 2020.
Murray's colleagues
We found three more compensation records of executives who worked with Mark Murray at Arbutus Biopharma Corp in 2019.
News
Jones Soda CEO David Knight receives $1.4M in 2023
April 3, 2024
Jones Soda CEO Mark Murray's 2022 pay rises 5% to $406K
April 5, 2023
Jones Soda CEO Mark Murray's 2021 pay jumps 58% to $386K
April 1, 2022
Jones Soda CEO Mark Murray's 2020 pay falls 94% to $243K
April 1, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020
Arbutus Biopharma Corp CEO Mark Murray's 2018 pay jumps 32% to $2.5M
April 23, 2019